Advertisement
Home 2016 September

Monthly Archives: September 2016

For adults with acute Plasmodium vivax or P. falciparum

KAF156 Active for Adults With Vivax, Falciparum Malaria

0
Antimalarial activity seen with multiple and single dose, with no serious adverse events
For preterm infants with early respiratory distress

Tx Failure Up for High-Flow Therapy Versus CPAP in Preemies

0
Significantly higher rate of treatment failure than CPAP in preterm infants with respiratory distress
In obese patients

Changes in Blood Microbiota in Obese With Liver Fibrosis

0
Among obese patients, 16S rDNA concentration significantly higher for those with liver fibrosis
Congenital brain abnormalities are similar for confirmed and presumed Zika infections

Findings to Help Radiologists ID Zika Virus Infection at Imaging

0
Similar brain abnormalities seen in confirmed and presumed congenital Zika infections
For patients with type 1 diabetes

Decline in eGFR Mainly Linear in Type 1 Diabetes

0
Trajectories in eGRF decline were linear for about 87 percent of patients, accelerating for 6 percent
Among children with persistent asthma

High Prevalence of Allergic Sensitization in Pediatric Asthma

0
Microarray methods provide new information in 47 percent of sensitized children
For asymptomatic patients with type 2 diabetes

CCTA Has Prognostic Value in Asymptomatic T2DM Patients

0
Excellent long-term prognoses for patients with normal coronary arteries, non-obstructive CAD
New guidelines have been issued by three leading cancer organizations for postmastectomy radiotherapy. All three groups published the guidelines online this week in their respective journals: the Journal of Clinical Oncology

ASCO/ASTRO/SSO Update Guidelines on Postmastectomy RT

0
Clear evidence that PMRT benefit extends to women with limited lymph node involvement
Patients who have an organ transplant may be more likely to develop skin cancer

Nonmelanoma Skin Cancer Risk Up in Organ Transplant Recipients

0
All recipients should have full-body skin evaluations after transplant surgery, regardless of ethnicity
Abuse of opioids costs the U.S. economy $78.5 billion a year

Economic Burden of U.S. Opioid Epidemic $78.5 Billion Annually

0
Costs includes health care, lost productivity, treatment programs